एपीए उद्धरण

Bramlage, P., Schmieder, R. E., Gitt, A. K., Baumgart, P., Mahfoud, F., Buhck, H., . . . Potthoff, S. A. (2015). The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: Insights from the prospective EARLY registry. Trials.

शिकागो स्टाइल उद्धरण

Bramlage, Peter, Roland E. Schmieder, Anselm K. Gitt, Peter Baumgart, Felix Mahfoud, Hartmut Buhck, Taoufik Ouarrak, Martina Ehmen, और Sebastian A. Potthoff. "The Renin-angiotensin Receptor Blocker Azilsartan Medoxomil Compared With the Angiotensin-converting Enzyme Inhibitor Ramipril in Clinical Trials Versus Routine Practice: Insights From the Prospective EARLY Registry." Trials 2015.

एमएलए उद्धरण

Bramlage, Peter, et al. "The Renin-angiotensin Receptor Blocker Azilsartan Medoxomil Compared With the Angiotensin-converting Enzyme Inhibitor Ramipril in Clinical Trials Versus Routine Practice: Insights From the Prospective EARLY Registry." Trials 2015.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.